Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Polynoma

Polynoma
2007 FOUNDED
M&A STATUS
IPO LATEST DEAL TYPE (Cancelled)
2 FINANCING ROUNDS
Description

Developer of oncology-focused biotechnology vaccine. The company's oncology-focused biotechnology offer novel polyvalent antigen therapy and seviprotimut-L, enabling pharmaceutical industry to provide vaccine for the treatment of melanoma.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • 11230 Sorrento Valley Road
  • Suite 215
  • San Diego, CA 92121
  • United States

Polynoma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Polynoma‘s full profile, request access.

Request full access to PitchBook